Liver transplantation for autoimmune hepatitis

Area of Science:

• Hepatology
• Transplant Immunology
• Autoimmune Diseases

Background:

• Autoimmune hepatitis (AIH) is a complex liver disease often requiring liver transplantation (LTX).
• While LTX outcomes for AIH are improving, issues like disease recurrence and rejection persist.
• Understanding pre- and post-transplant factors is key to optimizing patient outcomes.

Purpose of the Study:

• To evaluate the outcomes of liver transplantation (LTX) in patients with autoimmune hepatitis (AIH).
• To identify factors influencing recipient survival, disease recurrence, and rejection post-LTX for AIH.
• To assess the impact of AIH characteristics on LTX success and long-term prognosis.

Main Methods:

• Retrospective review of data from 32 patients who underwent LTX for AIH.
• Analysis of pre-transplantation clinical characteristics, including disease duration and severity.
• Evaluation of post-transplantation outcomes, focusing on survival, rejection episodes, and AIH recurrence rates.

Main Results:

• Excellent actuarial survival rates at 1 and 2 years post-LTX (81%).
• High frequency of rejection (75%), often requiring OKT3 treatment (39%).
• Recurrent AIH observed in 25% of long-term follow-up patients, with some requiring retransplantation and experiencing re-recurrence.

Conclusions:

• Liver transplantation (LTX) offers excellent outcomes for autoimmune hepatitis (AIH) patients.
• AIH patients undergoing LTX experience high rates of rejection and a significant risk of disease recurrence.
• Further multicenter studies are needed to optimize immunosuppressive strategies for AIH patients post-LTX.